Sleep Aids in the US

Sleep Aids in the US

Sleep aids is set to continue its decline in retail current value terms in the US in 2024, further offsetting the strong growth surge experienced during the peak pandemic years of 2020 and 2021, when many consumers faced severe stress-related insomnia. While the soft performances seen from 2022 can be seen as a gradual return to the pre-pandemic level of sales, the overall sleep space has experienced a renaissance in recent years as a result of the pandemic, with new product launches redefining...

Euromonitor International's Sleep Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.